Skip to main content

Table 2 Characteristics of ovarian cancer patients visiting HCP for BRCA1 or BRCA2 testing in British Columbia by serous status, 2001–2013

From: A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention

 

Serous ovarian cancer

N = 581

Endometrioid or clear cell ovarian cancers

N = 134

p-value

Age at diagnosis

60.0 ± 11.1

51.3 ± 11.0

< 0.001

Year of diagnosis

2007.9 ± 4.3

2005.3 ± 5.2

< 0.001

Age at time of first visit to HCP

62.3 ± 11.4

55.1 ± 11.3

< 0.001

Year of first visit to HCP

2009.6 ± 3.4

2008.4 ± 3.3

< 0.001

Index test

 Index

564 (97.1)

129 (96.3)

 

 Carrier

17 (2.9)

5 (3.7)

0.237

Proband status

 Yes

527 (90.7)

116 (86.6)

 

 No

54 (9.3)

18 (13.4)

0.151

Number of first degree relative

 0–3

423 (72.8)

97 (72.4)

 

 4–6

122 (21.0)

32 (23.9)

 

 7+

36 (6.2)

5 (3.7)

0.455

Number of second degree relatives

 0–3

257 (44.2)

58 (43.3)

 

 4–6

189 (32.5)

53 (40.0)

 

 7+

135 (23.2)

23 (17.1)

0.180

Number of third degree relatives

 0–3

303 (52.2)

62 (46.3)

 

 4–6

164 (28.2)

38 (28.4)

 

 7+

114 (19.6)

34 (25.4)

0.290

Number of fourth degree relatives

 0–3

545 (93.8)

122 (91.0)

 

 4–6

14 (2.4)

a < 5%

 

 7+

22 (3.8)

a < 5%

0.323

BRCA1 or BRCA2 positive

124 (21.3)

10 (7.5)

< 0.001

  1. aSuppressed due to small cell sizes so approximate percentages have been reported